Drug intelligence / Profile preview

Tissue Therapeutics hepatocyte therapy

Development stage
Preclinical
Lead developer
Xiangya Hospital, Central South University
Modality
iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Intrahepatic, Intralymphatic
01

Overview

Tissue Therapeutics hepatocyte therapy refers to a regenerative cell therapy approach that uses functional liver cells (hepatocytes) or hepatocyte-like cells, often derived from stem cells or mesenchymal stromal cells, to treat liver diseases such as end-stage liver disease and acute or acute-on-chronic liver failure. These therapies aim to restore lost hepatic function by engrafting new hepatocytes into the patient’s body, either directly into the liver or ectopically (such as in lymph nodes), where they can perform essential metabolic and synthetic functions of native liver tissue. The mechanism of action involves cell replacement and regeneration, anti-inflammatory effects, and stimulation of tissue repair. This field is under active clinical investigation with several approaches being developed by different companies and research groups[1][2][3][4][6].

02

Targets

IGF-1R (Insulin-like growth factor 1 receptor)MET (Mesenchymal-epithelial transition factor receptor)

Beyond the preview

Go deeper on Tissue Therapeutics hepatocyte therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue Therapeutics hepatocyte therapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call